Novel coronavirus (SARS-CoV-2) infection in a patient with multivisceral transplant

Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the history of modern public health, with particular emphasis in high-risk population. However, the evidence regarding their response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Papa Gobbi, Rodrigo, Bueno, Alba, Serradilla, J, Talayero, Paloma, Stringa, Pablo Luis, Pascual Miguel, Bárbara, Alcolea Sánchez, Alida, González Sacristan, Rocío, Andres, Ane M., López Santamaría, Manuel, Rumbo, Martín, Ramos Boluda, Esther, Hernández Oliveros, Francisco
Formato: Articulo
Lenguaje:Inglés
Publicado: 2020
Materias:
Ciencias Médicas
Virology
Coronavirus
Immunosuppression
Severe acute respiratory syndrome coronavirus
Transplantation
2019-20 coronavirus outbreak
Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
Coronavirus disease 2019 (covid-19)
Multivisceral transplantation
Medicine
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/125785
Aporte de:
SEDICI (UNLP) de Universidad Nacional de La Plata
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the history of modern public health, with particular emphasis in high-risk population. However, the evidence regarding their response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for COVID-19 is scant. Herein, we present the clinical and therapeutic course of a SARS-CoV-2 infection in a patient with multivisceral transplant and a recent tuberculosis infection.

Ejemplares similares